Home Privacy Archive Realtime Report

Stock Trading History of Kaye Jack

The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Kaye Jack since year 2005. The trader's CIK number is 1376099. At the time of this reporting, Kaye Jack is the Director of Keryx Biopharmaceuticals Inc (stock ticker symbol KERX).

Stock purchases, sales, and option exercises reported by *Kaye Jack* since 2005.
Trade Date	Symbol	Company Name (Issuer)	Trade Type	Shares	Price ($)	Value ($)
2007-06-19	KERX	Keryx Biopharmaceuticals Inc	Purchase	1,400	10.50	14,698

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kaye Jack (Director of Keryx Biopharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.